← Return to Bone turnover markers (CTX and P1NP): do you have a baseline?
DiscussionBone turnover markers (CTX and P1NP): do you have a baseline?
Osteoporosis & Bone Health | Last Active: 6 hours ago | Replies (197)Comment receiving replies
Replies to "@mayblin Looking back over this discussion , to refresh my memory as I will go in..."
I was in a similar situation last year when Cigna cut off my prior authorization for Tymlos after 4 months. I was off all medication for nearly three months until I could start teriparatide. My doctor was unconcerned and didn’t think this was a problem.
Hi @babbsjoy did you have a btm baseline, and btm labs during month 1-5 tymlos therapy? If so, any indication of anabolic effect from these data can serve as evidence that tymlos is working and should be sufficient to show your new endo imo. For some people, the biggest change in p1np is in early months 1-3 while on tymlos. It's also wise to get one done as you planned since btms most likely will change (in opposite direction) after you stop involuntarily.
I have read studies where btms ebbed and flowed with intermittent dosing of forteo (3mo on 3mo off); the resulting bmd changes at the end of study was just a bit shy of the regular daily dosing. Tymlos acts similar to Forteo, so hopefully btms and bmd outcome would be similar with interruption of the dosing, as in your case.
Hope other members who had similar dosing interruptions will chime in with experiences and outcomes. For the timebeing, take it easy - things will work out one way or the other. Keep us posted.